Home / People / Daniel Mahn
Portrait ofDaniel Mahn

Daniel Mahn

Counsel
Rechtsanwalt

CMS Hasche Sigle
Theodor-Heuss-Straße 29
70174 Stuttgart
Germany
Languages German, English

Daniel Mahn advises strategic investors and private equity funds on domestic and cross border M&A transactions. He acts both for buyers and sellers and takes over project coordination. His practice also covers company incorporations and restructurings as well as general corporate law matters.

Daniel has specialized in healthcare M&A transactions (particularly MVZ transactions) and he advises clients regularly on the acquisition of (single or joint) medical practices, laboratories and clinics.

Daniel co-authored the publication "Getting the Deal Through Healthcare M&A" together with Dr Christoph Lächler and Dr Roland Wiring.

Daniel joined CMS in 2015. He has been teaching law at the University of Heidelberg since 2018.

more less

Relevant experience

  • Seafort Advisors | Advice on the sale of VERTIKOM Group
  • PREMIUM Equity Partners | Advice on the acquisition of a majority share in CLARUS Films Group
  • NTT-DATA | Advice on the acquisition of gen-ius dms GmbH
  • NEXTCLINICS INTERNATIONAL GmbH | Advice on the acquisition of IVF-Zentren Prof. ZECH (group of private clinics)
more less

Publications

  • “Getting the Deal Through: Healthcare M&A, Country Report Germany, September 2019, Law Business Research Ltd.” (together with Dr Roland Wiring und Dr Christoph Lächler)
more less

Education

  • 2014: Second state examination in law
  • 2012 - 2014: Trainee lawyer at Stuttgart Regional Court
  • 2010 - 2012: Grading assistant at the University of Heidelberg
  • 2010: First state examination in law
  • 2004: Law studies at the University of Heidelberg
more less

Feed

08/10/2024
CMS advises ElringKlinger on sale of two Group companies to CERTINA Group
Stuttgart, 08.10.2024 – ElringKlinger AG, an independent global supplier to the automotive industry, has sold its subsidiaries in Sevelen (CH) and Buford (USA) to the CERTINA Group. El­ringK­linger’s plants in Sevelen and Buford manufacture shielding technology products for thermal and acoustic management in vehicles. The company generated revenue of approximately EUR 175 million at the two sites in 2023, with a combined headcount of around 650. This transaction is aimed at honing El­ringK­linger’s corporate profile and focusing the product portfolio along the path mapped out as part of its transformation strategy. The CERTINA Group is a family-owned industrial holding company. This deal adds two strong companies to its High Temperature Solutions division. The transaction is still subject to approval from the merger control authorities. The parties agreed not to disclose further details.A CMS team headed by lead partner Dr Christoph Lächler advised ElringKlinger AG on all legal aspects of the deal. The CMS team was supported by US law firm Barnes & Thornburg with regard to the US law aspects of the transaction. CMS Germany Dr Christoph Lächler, Lead Partner Daniel Mahn, Counsel Andreas Kazmaier, Senior Associate, all Corporate/M&A Dr Rolf Hempel, Partner, Antitrust, Competition & Trade Dr Marc Seibold, Partner Dr Anja Has­sel­mann-Thiede, Counsel, both Banking, Finance & Insurance Dr Martin Mohr, Partner, Tax CMS Switzerland Dr Stephan Werlen, LL.M., Part­ner Max­imili­an Hauser, Associate, both Corporate/M&A Helena Loretan, Associate, Real Estate Inhouse at ElringKlinger AG Dr Christof Dietborn, General Coun­sel Chris­toph­er Müller-Dahl, Senior Legal Counsel René Klein, Legal CounselPress Con­tact presse@cms-hs. com
03/09/2024
CMS advises SYNLAB International on the sale of SYNLAB Lietuva to Affidea...
Stuttgart, 03.09.2024 – SYNLAB International GmbH, a leading provider of medical diagnostics in Europe, has sold 100 percent of its shares in its Lithuanian subsidiary SYNLAB Lietuva UAB to Affidea Lietuva UAB. The Affidea Group is, according to its own information, the largest European provider of advanced diagnostic imaging, out-of-hospital treatment and cancer screening. With this transaction, SYNLAB intends to optimize its investment portfolio and focus more strongly on its core markets. The parties involved have agreed not to disclose further details.A CMS team headed by lead partner Dr Christoph Lächler provided comprehensive legal advice to SYNLAB International on the entire transaction. In particular, in addition to the purchase agreement documentation, an agreement on transitional services to be provided by the SYNLAB Group after completion of the transaction was also concluded. With regard to points of contact with Lithuanian law, the CMS team was supported by Deimantė Pagirienė of the World Law Group law firm COBALT Lithuania. Dr Fabian Walla, Group General Counsel, and Dr Peter Macheiner, Head of Legal M&A and Procurement, at SYNLAB in Munich, acted as in-house counsel. SYNLAB is a long-standing client of CMS and regularly relies on the expertise of the Corporate/M&A team led by Dr Christoph Lächler, most recently on the sale of its veterinary diagnostics division, SYNLAB VET, to a subsidiary of the US Mars Group. Press Con­tact presse@cms-hs. com
13/11/2023
CMS advises baking firm ARTiBack on acquisition by Schwarz Produktion
Stuttgart – ARTiBack GmbH, based in Halle (Saxony), has been sold to Schwarz Produktion, the umbrella brand for the Schwarz Group’s production facilities. Going forward, ARTiBack will help cover the...
28/09/2023
CMS advises on the sale of THS Group to Armor Print Solutions
Stuttgart – THS Group, a German specialist in solutions in printing consumables, spare parts and MPS software for photocopiers and printers, is joining forces with Armor Print Solutions, a company of...
14/08/2023
CMS advises SYNLAB on sale of Veterinary Diagnostics business to Mars
Stuttgart – The SYNLAB Group, a leading provider of medical diagnostic services and specialist tests in Europe, has sold its Veterinary Diagnostics business (SYNLAB VET) to a subsidiary of US group...
29/09/2022
CMS advises AEW on investment in Mobility as a Service provider AZOWO
Stuttgart – Mobility as a Service provider AZOWO GmbH has raised growth capital in a Series A financing round led by AEW Energie AG (AEW).A CMS team headed by Dr Christoph Lächler and Dr Florian Plagemann...
31/08/2021
CMS advises PE investor Demeter on investment in premium e-scooter manufacturer...
Stuttgart – Demeter, a major European private equity investor in the sustainability segment, has invested in Egret, a Hamburg-based developer and manufacturer of high-quality, foldable and innovative...
03/11/2020
CMS advises private equity firm Seafort Advisors on sale of Noventiz Group
Stuttgart – Private equity firm Seafort Advisors is selling the Noventiz Group, a certified waste management company and provider of packaging compliance services. The buyer is Reconomy Ltd., a leading...
26/06/2020
Apotal Group sells online pharmacy’s mail-order business and diabetes arm...
Stuttgart – Company founder Heinz-Peter Fichter and other shareholders have sold the mail-order business of online pharmacy Apotal and its diabetes division to the listed Zur Rose Group of Switzerland...
03/12/2019
CMS advises GPE and capiton on acquisition of NICOLAY Group
Stuttgart – The GPE Group has acquired all the shares in the NICOLAY Group, a manufacturer of products used for non-invasive patient monitoring. The deal further strengthens GPE’s expertise in medical...
14/10/2019
CMS advises Evago Group shareholders on investment by KKA Partners
Stuttgart – Evago Holding GmbH, one of the world’s leading companies in the field of temporary infrastructure, has gained Berlin-based investor KKA Partners as a strategic partner.A CMS team headed...
04/10/2019
Healthcare M&A
Getting the Deal Through – Healthcare M&A explores the main issues in healthcare M&A transactions. It also acts as a comparative legal guide for cross border or multi-jur­is­dic­tion­al activities and a...